Literature DB >> 19160178

Compression for venous leg ulcers.

Susan O'Meara1, Nicky A Cullum, E Andrea Nelson.   

Abstract

BACKGROUND: Around one percent of people in industrialised countries will suffer from a leg ulcer at some time. The majority of these leg ulcers are due to problems in the veins, resulting in an accumulation of blood in the legs. Leg ulcers arising from venous problems are called venous (varicose or stasis) ulcers. The main treatment has been a firm compression garment (bandage or stocking) in order to aid venous return. There is a large number of compression garments available and it is unclear whether they are effective in treating venous ulcers and which compression garment is the most effective.
OBJECTIVES: To undertake a systematic review of all randomised controlled trials of the clinical effectiveness of compression bandage or stocking systems in the treatment of venous leg ulceration.Specific questions addressed by the review are:1. Does the application of compression bandages or stockings aid venous ulcer healing? 2. Which compression bandage or stocking system is the most effective? SEARCH STRATEGY: For this update we searched the Cochrane Wounds Group Specialised Register (14/10/08); The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 4 2008); Ovid MEDLINE (1950 to October Week 1 2008); Ovid EMBASE (1980 to 2008 Week 41) and Ovid CINAHL (1982 to October Week 1 2008). No date or language restrictions were applied. SELECTION CRITERIA: Randomised controlled trials recruiting people with venous leg ulceration that evaluated any type of compression bandage system or compression hosiery were eligible for inclusion. Comparators included no compression (e.g. primary dressing alone, non-compressive bandage) or an alternative type of compression. Trials had to report an objective measure of ulcer healing in order to be included (primary outcome for the review). Secondary outcomes of the review included ulcer recurrence, costs, quality of life, pain, adverse events and withdrawals. There was no restriction on date, language or publication status of trials. DATA COLLECTION AND ANALYSIS: Details of eligible studies were extracted and summarised using a data extraction table. Data extraction was performed by one review author and verified independently by a second review author. MAIN
RESULTS: Overall, 39 RCTs reporting 47 comparisons were included.Review question 1: there was reasonable evidence from seven RCTs that venous ulcers heal more rapidly with compression than without.Review question 2: findings from six trials of single-component compression suggested that this strategy was less effective than multi-component compression. Evidence from compression systems with two components (3 trials) and three components (4 trials) suggested better outcomes when an elastic component was included. Different versions of compression with four-components (based on the Charing Cross four-layer bandage system) have similar effectiveness (3 trials). Compression with four components (variants of the Charing Cross four-layer bandage) is more effective than multi-component compression that includes a short-stretch bandage (6 trials). It is difficult to determine the relative effectiveness of the four-layer bandage compared with paste bandage systems because of differences in the paste systems (5 trials). There was no difference in effectiveness between the adjustable compression boot and compression bandages (2 trials) or between single-layer compression stockings and paste bandages (2 trials). Two-layer stockings appeared more effective than the short-stretch bandage (2 trials). The relative effectiveness of tubular compression when compared with compression bandages was not clear from current evidence (2 trials).Three trials reported ulcer recurrence; because of sparseness of data and trials not being primarily designed to assess this outcome, firm conclusions could not be drawn. Although several trials included cost data, only one reported a rigorously conducted cost-effectiveness analysis with findings suggesting that the four-layer bandage was more cost-effective than multi-component compression comprising a short-stretch bandage. Seven trials assessed health-related quality of life and none observed significant differences between treatment groups. Several trials evaluated pain either as a stand-alone outcome, or as part of the assessment of adverse events. In general, the data did not indicate clear differences between treatment groups. It is possible that stockings could be associated with less pain than bandages but in view of scarcity of available data this requires further evaluation. Many of the trials reported adverse events and / or withdrawals. Overall, these outcomes appeared similar across different treatment groups. AUTHORS'
CONCLUSIONS: Compression increases ulcer healing rates compared with no compression. Multi-component systems are more effective than single-component systems. Multi-component systems containing an elastic bandage appear more effective than those composed mainly of inelastic constituents.

Entities:  

Mesh:

Year:  2009        PMID: 19160178     DOI: 10.1002/14651858.CD000265.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  57 in total

1.  Efficacy and safety of a gauze pad containing hyaluronic acid in treatment of leg ulcers of venous or mixed origin: a double-blind, randomised, controlled trial.

Authors:  Philippe Humbert; Jacek Mikosinki; Hakima Benchikhi; François-André Allaert
Journal:  Int Wound J       Date:  2012-03-08       Impact factor: 3.315

Review 2.  Dogmas and controversies in compression therapy: report of an International Compression Club (ICC) meeting, Brussels, May 2011.

Authors:  Mieke Flour; Michael Clark; Hugo Partsch; Giovanni Mosti; Jean-Francois Uhl; Michel Chauveau; Francois Cros; Pierre Gelade; Dean Bender; Anneke Andriessen; Jan Schuren; André Cornu-Thenard; Ed Arkans; Dragan Milic; Jean-Patrick Benigni; Robert Damstra; Gyozo Szolnoky; Franz Schingale
Journal:  Int Wound J       Date:  2012-06-21       Impact factor: 3.315

3.  Successful treatment of two refractory venous stasis ulcers treated with a novel poly-N-acetyl glucosamine-derived membrane.

Authors:  Erik Alberto Maus
Journal:  BMJ Case Rep       Date:  2012-07-09

4.  A prospective, multi-centre, randomised, open label, parallel, comparative study to evaluate effects of AQUACEL® Ag and Urgotul® Silver dressing on healing of chronic venous leg ulcers.

Authors:  Keith Harding; Finn Gottrup; Arkadiusz Jawień; Jacek Mikosiński; Krystyna Twardowska-Saucha; Sławomir Kaczmarek; Maciej Sopata; Cliff Shearman; Alaine Pieronne; Dheerendra Kommala
Journal:  Int Wound J       Date:  2011-11-09       Impact factor: 3.315

Review 5.  Knowns and Unknowns in Managing Postthrombotic Syndrome.

Authors:  Suresh Vedantham
Journal:  Semin Intervent Radiol       Date:  2017-03       Impact factor: 1.513

6.  Factors that influence perforator thrombosis and predict healing with perforator sclerotherapy for venous ulceration without axial reflux.

Authors:  Misaki M Kiguchi; Eric S Hager; Daniel G Winger; Stanley A Hirsch; Rabih A Chaer; Ellen D Dillavou
Journal:  J Vasc Surg       Date:  2014-01-06       Impact factor: 4.268

Review 7.  Biofabrication of thick vascularized neo-pedicle flaps for reconstructive surgery.

Authors:  Chelsea J Stephens; Jason A Spector; Jonathan T Butcher
Journal:  Transl Res       Date:  2019-05-21       Impact factor: 7.012

8.  Keratin-based Wound Care Products for Treatment of Resistant Vascular Wounds.

Authors:  Martin P Than; Robert A Smith; Catherine Hammond; Robert Kelly; Clive Marsh; Andrea D Maderal; Robert S Kirsner
Journal:  J Clin Aesthet Dermatol       Date:  2012-12

9.  Multifaceted management of the postthrombotic syndrome.

Authors:  Lina Nayak; Suresh Vedantham
Journal:  Semin Intervent Radiol       Date:  2012-03       Impact factor: 1.513

Review 10.  Graduated compression stockings.

Authors:  Chung Sim Lim; Alun H Davies
Journal:  CMAJ       Date:  2014-03-03       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.